Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Acacia honey accelerates in vitro corneal ulcer wound healing model

  • Norzana Abd Ghafar1Email author,
  • Choy Ker-Woon1,
  • Chua Kien Hui2,
  • Yasmin Anum Mohd Yusof3 and
  • Wan Zurinah Wan Ngah3
BMC Complementary and Alternative MedicineBMC series – open, inclusive and trusted201616:259

https://doi.org/10.1186/s12906-016-1248-0

Received: 22 April 2016

Accepted: 23 July 2016

Published: 29 July 2016

Abstract

Background

The study aimed to evaluate the effects of Acacia honey (AH) on the migration, differentiation and healing properties of the cultured rabbit corneal fibroblasts.

Methods

Stromal derived corneal fibroblasts from New Zealand White rabbit (n = 6) were isolated and cultured until passage 1. In vitro corneal ulcer was created using a 4 mm corneal trephine onto confluent cultures and treated with basal medium (FD), medium containing serum (FDS), with and without 0.025 % AH. Wound areas were recorded at day 0, 3 and 6 post wound creation. Genes and proteins associated with wound healing and differentiation such as aldehyde dehydrogenase (ALDH), vimentin, alpha-smooth muscle actin (α-SMA), collagen type I, lumican and matrix metalloproteinase 12 (MMP12) were evaluated using qRT-PCR and immunocytochemistry respectively.

Results

Cells cultured with AH-enriched FDS media achieved complete wound closure at day 6 post wound creation. The cells cultured in AH-enriched FDS media increased the expression of vimentin, collagen type I and lumican genes and decreased the ALDH, α-SMA and MMP12 gene expressions. Protein expression of ALDH, vimentin and α-SMA were in accordance with the gene expression analyses.

Conclusion

These results demonstrated AH accelerate corneal fibroblasts migration and differentiation of the in vitro corneal ulcer model while increasing the genes and proteins associated with stromal wound healing.

Keywords

Acacia honey Corneal fibroblasts In vitro corneal ulcer Wound healing

Background

Corneal wound healing is an exceptionally complex and dynamic process, which is regulated by various growth factors, cytokines, extracellular matrix components and involves intercommunication of various cells [1]. Keratocytes, the quiescent cell type located in the stromal layer, are responsible for generation of the extracellular matrix and maintenance of the shape and transparency of the cornea [2].

Corneal ulcer, either due to traumatic or infective aetiologies, causes disruption of the epithelial layer or may extend deep into the stroma. Stromal reaction upon injury involves apoptosis of the adjacent keratocytes at the wound area while more distant keratocytes become activated to transform into repair phenotypes, the corneal fibroblasts, to reconstruct the damaged stroma and later into myofibroblasts which facilitate wound closure [3]. Corneal fibroblasts then migrate into the wound area triggered by cytokines such as bFGF (basic fibroblast growth factor), insulin-like growth factor 2 and TGFβ1 (transforming growth factor β1) produced by epithelial cells, stromal cells, inflammatory cells, and lacrimal gland cells [1]. The healing process also involves the restoration of corneal transparency, production, deposition and degradation of extracellular matrix components, and scar remodeling [4]. Migration and phenotypical transition of quiescent keratocytes to active phenotypes; corneal fibroblasts and myofibroblasts are the key processes in stromal wound healing.

One of the major concerns in the usage of topical antibiotic or antifungal eye drop in treating corneal injury is the development of resistance and the presence of preservatives that can cause various side effects such as corneal epithelial damage and conjunctival inflammation [5, 6]. Hence, there is a need to search for an alternative or adjunct treatment for corneal injury. Many researchers have directed their focus on the potentiality of natural products in treating various diseases and trying to alleviate the drawbacks of the conventional therapy.

Honey, a carbohydrate-rich natural product originated from floral nectars, has been reported to possess antibacterial, anti-inflammatory and antioxidant properties [7]. Acacia honey (AH) is a monofloral honey produced by Apis mellifera honeybees from Acacia mangium trees and flowers. It has been documented to accelerate wound contraction in rats, increasing skin-breaking strength and promotes tissue granulation [8]. We hypothesize that AH may exert the same favourable effects on the stromal derived corneal fibroblasts as it has demonstrated on the dermal fibroblasts.

This study aimed to investigate the effects of AH in migration and differentiation during wound healing of corneal fibroblasts. For this purpose, we developed an in vitro corneal ulcer model using 4 mm corneal trephine onto confluent rabbit corneal fibroblasts culture. We hypothesized that supplementation of AH in the culture media promotes the centripetal migration and accelerates healing of the corneal fibroblasts in this ulcer model.

Methods

This study was performed following approval from the Research and Ethical Committee of Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM project code: GGPM-2011-085) and Universiti Kebangsaan Malaysia Animal Ethics Committee (project code: UKMAEC Approval Number FP/ANAT/2012/ NORZANA/ 18-JANUARY/ 419-JANUARY-2011-DECEMBER-2013-AR-CAT2).

Acacia honey (AH)

Acacia honey (AH) was purchased from Ministry of Agriculture, Malaysia and gamma irradiated at 25 kGy at Ministry of Science, Technology and Innovation, Malaysia. Our previous study revealed that the optimal concentration of AH was 0.025 % [9]. The same study observed that the AH was not cytotoxic at the range of 0–3.125 % concentrations using H2O2 at the concentration of 1.56nM as positive control [9].

Isolation and culture of rabbit stromal derived corneal fibroblasts

Primary cultures of corneal stromal cells were isolated and cultured as described previously [10]. Briefly, six New Zealand white strain rabbits’ corneas (2.0–2.5 kg) were excised by circular incision 2 mm beyond the corneoscleral junction. Connective tissue such as endothelium, ocular muscle, sclera, ciliary body and iris were stripped off and discarded. Following rinsing with phosphate buffered solution (Gibco Invitrogen, USA), corneas were immersed in Dispase solution 2 mg/ml (Sigma-Aldrich, USA) at 4 °C for 18 h to dissociate the stromal layer from the epithelium. Loose epithelial layer were gently removed with a scalpel (Fisher Scientific, Los Angeles, CA) and the remaining stroma was rinsed, sliced and digested with 0.3 % collagenase type I with intermittent gentle shaking at 37 °C for 90 min. The digested stroma was centrifuged at 500 x g for 10 min and the resultant pellet was washed twice with phosphate buffered solution (PBS, pH 7.2, Gibco Invitrogen, USA) to remove the remaining enzyme. Viable stromal cells were seeded in T75 cm2 culture flask (BD Falcon, Franklin Lakes, NJ) with seeding density of 5 × 104 cell/cm2 in medium containing serum (FDS) consisting of Ham’s F-12: Dulbecco’s Modified Eagle’s Medium (Gibco), with 10 % foetal bovine serum (FBS; Gibco), 1 % of antibiotic and antimitotic (Gibco), 1 % of 50 μg/ml ascorbic acid (Sigma, St. Louis, USA). Stromal derived corneal fibroblasts were cultured in a 5 % CO2 incubator (Jouan, Duguay Trouin, SH) under 95 % humidity at 37 °C. At 80 % confluence, the primary culture (P0) was trypsinized using 0.125 % trypsin-EDTA (Gibco) and subcultured to passage 1 (P1) in FDS with seeding density of 5 × 103 cells/cm2 in six well-plates (BD Falcon, Franklin Lakes, NJ) under the same condition as the primary culture. Medium was changed every 2 days and the cultures were monitored everyday using inverted phase contrast microscope (Carl Zeiss, Germany) to examine the morphological changes or any sign of contamination.

Cell migration study and in vitro corneal ulcer healing model

To evaluate the migration of corneal fibroblasts, a defect was created onto confluent monolayer culture. Corneal fibroblasts at passage 1 were seeded in the six well plates (BD Falcon, Franklin Lakes, NJ) at the density of 5 × 103 cells/cm2 in FDS medium until it reached confluence at day 3. The medium was discarded and corneal ulcer was created using 4 mm corneal trephine onto the confluent monolayer corneal fibroblasts culture. The cells within the circumference of the wound were gently scraped off using a sterilized cotton bud. The cultures were rinsed twice with PBS after wounding to remove non-adherent cells and cultured in four different media; basal medium (FD), medium containing serum (FDS), FD with supplementation of 0.025 % AH (AH-enriched FD medium), and FDS with supplementation of 0.025 % AH (AH-enriched FDS medium). Cells were cultured at 37 °C in a 5 % CO2 incubator and media were changed every 3 days. The wound area was measured using Axiovision LE64 software and the percentage of wound closure was quantified by measuring the average percentage of wound closure (n = 6 independent experiments) by migrating cells at the wound edges in the initial day of wounding (day 0), day 3 and day 6 post wound creation (Fig. 1) using the formula below:
Fig. 1

Schematic diagram of in vitro corneal ulcer model using 4 mm corneal trephine onto confluent monolayer corneal fibroblasts at P1. Y represents the wound area at the initial day of experiment (Day 0) and Z represents the wound area at day 3 or day 6 post wound creation

Formula:
$$ \mathrm{Wound}\ \mathrm{closure} = \kern0.87em \frac{\mathrm{Y}-\mathrm{Z}}{\mathrm{Y}} \times 100\% $$
$$ Y = \mathrm{Initial}\ \mathrm{wound}\ \mathrm{area} $$
$$ Z = \mathrm{Wound}\ \mathrm{area}\ \mathrm{at}\ \mathrm{day}\ 3\ \mathrm{or}\ \mathrm{day}\ 6 $$

Morphological assessment, gene expression and immunocytochemistry analyses were performed at the same time point of the cell migration study.

Gene expression of wound healing markers

Total RNA from corneal fibroblasts cultured in four different media at day 0, day 3 and day 6 following in vitro wound creations were extracted using TRI Reagent (Molecular Research Centre, Cincinnati, USA) according to the manufacturer’s protocol. In brief, chloroform was added into the homogenate to isolate the transparent aqueous contained total RNA. Isopropanol and Polyacryl carrier (Molecular Research Centre) were added to each extraction to precipitate the total RNA. The extracted RNA pellet was washed with 75 % ethanol and air dried before dissolving it in Rnase and Dnase free distilled water (Invitrogen, Carlsbad, USA). Complementary DNA was synthesized from 100 ng of Total RNA with Super Script™ III First-Strand Synthesis Super Mix reverse transcriptase (Invitrogen, Carlsbad, USA). The protocol conditions were 10 min at 23 °C for primer annealing, 60 min at 50 °C for reverse transcription and 5 min at 85 °C for reaction termination. The expression of aldehyde dehydrogenase (ALDH), vimentin, alpha-smooth muscle actin (α-SMA), collagen type I, lumican and matrix metalloproteinase 12 (MMP12) were evaluated by two-step reverse transcriptase-polymerase chain reaction (Invitrogen, Carlsbad, USA). Positive control was observed using GAPDH primer pairs. All gene-specific primers used are shown in Table 1. The two-step RT-PCR reaction was performed using SYBR Green as the indicator in a Bio-Rad iCycler (Bio-Rad, USA). RT-PCR was carried out using 12.5 μl of iQ SYBR Supermix, 1 μl each of forward and reverse primers (GenBank, using Primer-3), 8.5 μl deionized water and 1 μl of cDNA template. The cycling conditions for all primer pairs were as follows: cycle 1: 95 °C for 3 min (1×), cycle 2: Step 1 95 °C for 10 s and Step 2 61 °C for 30 s (40×), followed by melting curve analysis. The specificity and PCR product size were visualized by 2 % agarose gel electrophoresis with ethidium bromide staining.
Table 1

Description of primers used in qRT-PCR

Primer

Accession Number

Primer Sequence

Product size

GADPH

NM_001082253

F:caa cga att tgg cta cag ca

186

R:aaa ctg tga aga ggg gca ga

ALDH

AY508694

F:gag tgg cat gat tca gtg agc

186

R:gag tag tcg tcc cct ctt gga

Vimentin

AY465353.1

F: tgc agg aag aga ttg cct tt

117

R: tga ggt cag gct tgg aga ca

α-SMA

X60732

F: tcg aca tca gga agg acc tct

206

R: cat ctg ctg aaa ggt gga cag

Lumican

AF020292

F: ctg cag ctt acc cac aac aag

160

R: ggt tga agc tca agt cca ggt

Collagen type I

AY633633

F: gcg gag agt act gga ttg acc

163

R: cac acg tgc ttc ttc tcc ttg

MMP12

AB006779

F: tga agc gtg agg atg ttg ag

181

R: aaa gca tgg gct atg aca cc

Immunocytochemistry

Corneal fibroblasts cultured on cover glass in four different media at day 0, day 3 and day 6 post wound creation were fixed with 4 % paraformaldehyde at 4 °C using standard protocol from Dako Animal Research Kit. Briefly, the slides were rinsed with running tap water for 3 min. Following incubation with blocking agent (0.03 % peroxidase block) at room temperature for 5 min, cells were labelled using the Biotinylation reagent and incubated with primary antibodies for 30 min. Primary antibodies used were anti-ALDH (1:100, Dako), anti-Vimentin (1:200, Dako) and anti-α-SMA (1:100, Dako). Biotinylation reagent was mixed to bind biotinylated secondary antibody to the primary antibody. The specimen was then incubated with streptavidin-peroxidase, followed by reaction with diaminobenzidine/hydrogen peroxide as substrate-chromogen. Nuclei were stained with haematoxylin (Sigma). Positive stained cells exhibited brownish precipitate in the cytoplasm. Coverslips were mounted using DPX mounting medium (Sigma Aldrich Co, USA) and slides were observed using confocal laser scanning microscope (LSM-510, Zeiss).

Data analysis

Values were expressed as mean ± standard error of mean (SEM). The data was analyzed with paired t-test and ANOVA using SPSS version 20.0 and the p value of <0.05 was considered to be significant.

Results

Morphology of the corneal fibroblasts at the wound edge

Corneal fibroblasts underwent centripetal migration within 3 h post wound creation. Cells at the wound edge changed morphology to become spindle-shaped cells resembling active fibroblast (Fig. 2).
Fig. 2

Phase contrast micrograph representing one ninth of the whole wound edge of the corneal fibroblasts (P1) cultured in four different media; 1) FD medium (a, b, c), 2) AH-enriched FD medium (d, e, f), 3) FDS medium (g, h, i), and 4) AH-enriched FDS medium (j, k, l). Spindle-shaped cells resembling active fibroblasts are shown by arrows. The wound area was observed at day 0, day 3 and day 6 post wound creation. Magnification ×20

Cell migration study and in vitro corneal ulcer healing model

Cell migration study signifies the centripetal migration of the corneal fibroblast in closing the wound. The cells cultured in AH-enriched FD and FDS media showed higher percentage of wound closure compared to their respective controls (Fig. 3). At day 3, cells cultured in AH-enriched FD medium showed a 27.4 % reduction in the wound size compared to 19.5 % for cells cultured in FD medium alone (Fig. 3b, e and 4). Cells cultured in AH-enriched FDS medium reduced the wound area to 49.9 % compared to that of 44.5 % for cells cultured in FDS medium alone (Fig. 3h, k and 4). At day 6, the migration of cells were significantly slower in FD medium compared to AH-enriched FD medium which showed 30.8 and 39.5 % wound closure respectively (Fig. 3c, f and 4). Cells cultured in AH-enriched FDS medium showed complete wound closure at day 6 (Fig. 3l), compared to only 81.5 % wound closure in the FDS medium alone (Fig. 3i and 4). These results indicate that AH at the concentration of 0.025 % has significant effect in accelerating the migration of the cultured corneal fibroblasts of the in vitro corneal ulcer model.
Fig. 3

Micrographs showed the wound area of cultured corneal fibroblasts stained with H & E at passage 1 in four different media; 1) FD medium (a, b, c), 2) AH-enriched FD medium (d, e, f), 3) FDS medium (g, h, i), and 4) AH-enriched FDS medium (j, k, l). The wound area was observed at day 0, day 3 and day 6 post wound creation. Magnification ×20

Fig. 4

Cell migration study of corneal fibroblasts cultured in four different media of the in vitro wound healing model (n = 6 independent experiments). (*) denotes significant difference (p < 0.05) between the same medium while (#) denotes significant difference (p < 0.05) between different media

Gene expression of the differentiation and wound healing markers

The differentiation and wound healing markers were evaluated by gene expression study. The expression of ALDH was the highest at the initial day of wound creation in all groups (Fig. 5a). At day 3, the expression of ALDH reduced significantly in FDS and AH-enriched FDS media compared to FD and AH-enriched FD media, respectively. At day 6, corneal fibroblasts cultured in AH-enriched media significantly reduced the expression of ALDH compared to their respective controls. In contrast, vimentin showed increasing expression pattern from the initial day of wound creation until day 6 in all groups (Fig. 5b). Cells cultured in AH-enriched FDS media showed the highest vimentin expression compared to FDS medium alone.
Fig. 5

Gene expression of corneal fibroblasts differentiation and wound healing markers; a ALDH, b Vimentin, c α-SMA, d collagen type I, e lumican and f MMP12 for corneal fibroblasts cultured in four different media. Values were expressed as mean ± SEM, n = 6 independent experiments. (*) denotes significant difference (p < 0.05) between the same medium (#) denotes significant difference (p < 0.05) between different media

Cells showed increasing trend of α-SMA expression, compared to the initial day of wounding in all groups (Fig. 5c). At day 6, corneal fibroblasts cultured in FDS medium showed higher expression of α-SMA compared to FD medium. However, the expression of α-SMA was significantly reduced in AH-enriched FDS media. The expression of collagen type I gene was up-regulated at day 3 and day 6 in comparison to the initial day of wound creation in all groups (Fig. 5d). Corneal fibroblasts cultured in AH-enriched FDS medium showed the highest expression of collagen type I compared to control medium at day 6 of wound creation.

The expression of lumican was up-regulated for cells cultured in all media (Fig. 5e). At day 6, expression of lumican increased significantly (p < 0.05) when corneal fibroblasts were cultured in AH-enriched media compared to their respective controls. Gene expression of MMP12 was the lowest at the initial day of wound creation in all media (Fig. 5f). At day 3, MMP12 gene expression was up-regulated, especially in cells cultured in AH-enriched FDS medium compared to FDS medium alone. At day 6, corneal fibroblasts cultured in FDS groups showed reduction in the gene expression of MMP12 compared to the FD groups.

Gel electrophoresis showed specific product size with the presence of single band for gene expression of ALDH, vimentin, α-SMA, collagen type I, lumican and MMP12 in corneal fibroblasts cultured with or without supplementation of 0.025 % AH (Fig. 6).
Fig. 6

Gel electrophoresis for confirmation of product size of cultured corneal fibroblasts in four different media; (1) FD, (2) AH-enriched FD medium, (3) FDS and (4) AH-enriched FDS medium. GADPH gene was used as internal control

Immunocytochemistry

The protein expression during wound healing was ascertained through immunohistochemistry. Abundant positive brown stained cells for ALDH protein was detected at the wound edge at the initial day of wounding in all groups (Fig. 7a, d, g, j). The protein expression was reduced during day 3 (Fig. 7b, e h, k) and day 6 in AH-enriched media compared to their respective controls (Fig. 7c, f, i, l).
Fig. 7

Immunocytochemistry staining for ALDH protein of corneal fibroblasts cultured in four different media; 1) FD medium (a, b, c), 2) AH-enriched FD medium (d, e, f), 3) FDS medium (g, h, i), and 4) AH-enriched FDS medium (j, k, l) at day 0, day 3 and day 6 post wound creation. Magnification ×50

Vimentin was highly expressed throughout the study in all culture media (Fig. 8). The density of positive stained cells was increased in cell cultured in FD (Fig. 8b, e, c, f) and FDS (Fig. 8h, k i, l) media supplemented with 0.025 % AH compared to control media at day 3 and day 6 post wounding.
Fig. 8

Immunocytochemistry staining for vimentin protein of corneal fibroblasts cultured in four different media; 1) FD medium (a, b, c), 2) AH-enriched FD medium (d, e, f), 3) FDS medium (g, h, i), and 4) AH-enriched FDS medium (j, k, l) at day 1, day 3 and day 6 post wound creation. Magnification ×50

At the initial day of wounding, α-SMA protein expression was reduced in all groups (Fig. 9a, d, g, j). At day 3 and day 6, α-SMA protein expression were increased especially in corneal fibroblasts cultured in AH-enriched media (Fig. 9e, f, k, l) compared to controls, respectively (Fig. 9b, c h, i), indicating the presence of myofibroblasts phenotype in the wound. All the immunocytochemistry results were in agreement with the gene expression analyses.
Fig. 9

Immunocytochemistry staining for α-SMA protein of corneal fibroblasts cultured in four different media; 1) FD medium (a, b, c), 2) AH-enriched FD medium (d, e, f), 3) FDS medium (g, h, i), and 4) AH-enriched FDS medium (j, k, l) at day 1, day 3 and day 6 post wound creation. Magnification ×50

Discussion

The process of corneal stromal healing involved the activation of quiescent keratocytes and transition into repair phenotypes; the corneal fibroblasts and myofibroblasts. These repair phenotypes are important to stimulate the regeneration of the corneal tissue during stromal wound healing [11]. Corneal fibroblasts migrate and synthesize new extracellular matrix, while myofibroblasts are essential for wound contraction during healing [12, 13].

The present study showed corneal fibroblasts in AH-enriched media promotes faster migration and wound closure compared to controls, respectively. This is due to the presence of glucose in AH that provides main source of energy for cell proliferation and growth [14]. Previous study from this group showed AH increased the proliferative capacity of corneal fibroblasts in vitro [9].

Glucose provides energy during angiogenesis and deposition of new tissue [15]. AH has been reported to possess the highest sugar content compared to other honeys in Malaysia and this provides metabolic support for the migration and proliferation of corneal fibroblasts in corneal wound healing [16]. Previous study revealed AH enhanced granulation of the skin of the rats with burn injury [8]. Similar results were reported in other in vivo researches using Gelam honey, Chestnut honey, Blossom honey and Phododendron honey on rats’ skin wound healing [17, 18].

Hydrogen peroxide is a strong antibacterial agent for Escherichia coli and Pseudomonas aeruginosa in vitro [19]. Bang et al. (2003) reported hydrogen peroxide was produced at low concentration and in a continuous manner when honey was diluted [20]. Previous study demonstrated that low concentration of hydrogen peroxide ranging from 10 nM to 1 μM was sufficient to stimulate the migration of hamster and rat fibroblasts in vivo after injury [21]. Hydrogen peroxide provided adequate oxygen and nutrient to the injured tissue through angiogenesis [22]. This antibacterial function of hydrogen peroxide in the AH provides a favourable and optimal culture condition for the migration and proliferation of corneal fibroblasts during wound closure.

Chronic wounds have a raised alkaline environment. Honey has been reported to lessen wound pH, reduce protease activity, increase fibroblasts activity and elevate oxygen release which in turn facilitates in wound healing [23]. Other research demonstrated that acidic pH promotes wound contraction by myofibroblasts in the skin [24]. Hence, AH with the pH of 3.53 was optimal for corneal fibroblasts migration in wound healing [16].

The healing process of the corneal stroma starts with the initiation of neighbouring keratocytes migrating to the acellular region at the edge of the wound [2]. Keratocytes increase in size and number, leading to reduction of expression of corneal crystallins such as ALDH and loss of cellular transparency [25]. ALDH expression was down-regulated significantly in AH-enriched FDS medium. The presence of serum or growth factors stimulated transition of quiescent keratocytes into corneal fibroblasts and myofibroblasts phenotypes which in turn lowered the expression of ALDH [26]. The repair phenotypes were not reversible to become quiescent keratocytes even with subsequent culture of the corneal fibroblasts in the serum-free medium [27]. Immunocytochemistry finding of ALDH protein was in accordance to the gene expression results.

During healing, spindle-shaped corneal fibroblasts migrated into the acellular region within 24 h and synthesized extracellular matrix [2]. The expression of stromal proteins such as vimentin, decorin and keratocan was reported to increase following keratoconus surgery [28]. Growth factors such as fibroblast growth factor-2 (FGF-2) and platelet-derived growth factor (PDGF) in the serum or in the culture medium initiate the stromal keratocytes to differentiate into corneal fibroblasts or myofibroblasts comparable to the keratocytes reaction to injury in vivo [29]. Immunocytochemistry staining for vimentin was increased 1 week following photorefractive keratectomy in the rabbit cornea and 2 weeks following cornea alkaline abrasion in rabbit [30, 31]. Corneal fibroblasts cultured in AH-enriched FDS media expressed the highest vimentin level indicating the proliferation during wound closure. Application of AH onto injured skin was reported to promote wound contraction by dermal fibroblasts [32].

Myofibroblasts, which are characterized by the presence of α-smooth muscle actin (α-SMA), appeared during the contraction phase of corneal wound healing [33]. Myofibroblasts differentiation is associated with dilution of corneal crystallins and reduction of mRNA levels for ALDH [13]. Our study showed an increasing trend of α-SMA expression for corneal fibroblasts treated with AH-enriched media which indicates that AH induced the differentiation of corneal fibroblasts to myofibroblasts during healing. Jester et al. (1995) reported a direct association between the expressions of α-SMA with the stages of corneal wound contraction [34]. Disappearance of myofibroblasts during complete wound closure was mediated by apoptosis and differentiation of myofibroblasts back to fibroblasts during stromal re-remodeling leading to regression of corneal haze [35]. Similarly, our study showed the reduction in the α-SMA expression during wound closure in the AH-enriched FDS medium and this favourable finding indicates the potential of AH in reducing corneal opacity and scarring.

During stromal wound healing, the mRNA expression of collagen type I and V were increased in both fibroblasts and myofibroblasts [26, 31]. The up-regulation of collagen type I in AH-enriched media was in agreement to the findings of the full-thickness wound injury in the rat treated with honeybee venom [36].

Lumican is expressed by quiescent keratocytes in normal unwounded cornea and plays an important role in corneal transparency through the regulation of collagen matrix assembly [4]. The increase expression of lumican in the AH-enriched media indicates the potential role of AH in promoting corneal transparency during corneal wound healing.

Matrix metalloproteinase-12 (MMP12) is essential in tissue remodelling during corneal wound healing [37]. Following corneal injury, a glycoprotein called extracellular matrix metalloproteinase inducer is produced on the surface of corneal epithelial cells which interact with corneal fibroblasts to produce MMP and induce myofibroblasts differentiation [38]. Keratocytes and fibroblasts expressed abundant MMP12 only during the acute phase but reduced during final stages of wound healing as transforming growth factor-β1 (TGF-β1) induced the differentiation of fibroblasts to myofibroblasts [39]. The presence of TGF-β1 in the serum may explain the down-regulation of MMP12 in corneal fibroblasts cultured in FDS medium with or without supplementation of AH.

There were few limitations in the study. The mechanism of action of AH could be well explained if a mixture of carbohydrates such as glucose and fructose, similar to that of AH composition, is included as a control. This aspect would be dealt in detail in future studies to elucidate the mechanism of wound healing by AH. We did not use any drug as positive control because the ulcer created was not due to any infective cause.

Conclusion

In conclusion, the supplementation of Acacia honey into the culture media accelerates rabbit corneal fibroblasts migration and differentiation of the in vitro corneal wound healing model. The close similarity of the anatomical structure of rabbit cornea to the human cornea serves as a basis for the relevance of the above findings. This provides an opportunity for the development of honey-based eye drop for therapeutic purposes or as an adjunct in treating corneal injury in the future.

Abbreviations

AH, acacia honey; ALDH, aldehyde dehydrogenase; bFGF, basic fibroblast growth factor; FBS, foetal bovine serum; FD, basal medium; FDS, medium containing serum; MMP12, matrix metalloproteinase 12; P1, passage 1; qRT-PCR, real time quantitative reverse transcription polymerase chain reaction; SEM, standard error of mean; TGFβ1, transforming growth factor β1; α-SMA, alpha-smooth muscle actin

Declarations

Acknowledgements

The authors would also like to thank the staff of Anatomy, Physiology and Biochemistry Departments for their technical assistance and Prof Dr Srijit Das for editing this paper.

Funding

The authors acknowledge the financial support received from the UNIVERSITI KEBANGSAAN MALAYSIA grant GGPM-2011-085.

Availability of data and materials

The datasets supporting the study are included within the text of the article.

Authors’ contributions

NAG designed the research, analysed data and drafted the manuscript. CKW performed the experiments, analysed data and drafted initial part of the manuscript. CKH, YAMH and WZWN involved in discussion, analysed data and manuscript editing. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Ethics approval and consent to participate

Ethical approval was obtained (UKMAEC Approval Number FP/ANAT/2012/ NORZANA/ 18-JANUARY/ 419-JANUARY-2011-DECEMBER-2013-AR-CAT2). Consent does not apply as no human subjects were used.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC)
(2)
Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC)
(3)
Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre (UKMMC)

References

  1. Lim M, Goldstein MH, Tuli S, Schultz GS. Growth factor, cytokine and protease interactions during corneal wound healing. Ocul Surf. 2003;1(2):53–65.View ArticlePubMedGoogle Scholar
  2. Fini ME. Keratocyte and fibroblast phenotypes in the repairing cornea. Prog Ret Eye Res. 1999;8(4):529–51.View ArticleGoogle Scholar
  3. West-Mays JA, Dwivedi DJ. The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol. 2006;38(10):625–1631.View ArticleGoogle Scholar
  4. Carlson EC, Lin M, Liu CY, Kao WW, Perez VL, Pearlman E. Keratocan and lumican regulate neutrophil infiltration and corneal clarity in lipopolysaccharide-induced keratitis by direct interaction with CXCL1. J Biol Chem. 2007;282(49):35502–9.View ArticlePubMedPubMed CentralGoogle Scholar
  5. McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36(9):1588–98.View ArticlePubMedGoogle Scholar
  6. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23(5):490–6.View ArticlePubMedGoogle Scholar
  7. Mohd Zohdi R, Abu Bakar Zakaria Z, Yusof N, Mohamed Mustapha N, Abdullah MN. Gelam (melaleuca spp.) honey-based hydrogel as burn wound dressing. Evid Based Complement Altern Med. 2012;2012:843025. 10.1155/2012/843025.View ArticleGoogle Scholar
  8. Iftikhar F, Arshad M, Rasheed F, Amraiz D, Anwar P, Gulfraz M. Effects of acacia honey on wound healing in various rat models. Phytother Res. 2010;24(4):583–6.PubMedGoogle Scholar
  9. Ker-Woon C, Abd Ghafar N, Hui CK, Mohd Yusof YA. Effect of acacia honey on cultured rabbit corneal keratocytes. BMC Cell Biol. 2014;15:19. 10.1186/1471-2121-15-19.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Abd Ghafar N, Chua KH, Wan Ngah WZ, Che Hamzah J, Othman F, Abd Rahman R, Hj IR. Phenotypic characterization of culture expanded rabbit limbal corneal keratocytes. Cell Tissue Bank. 2014;15(1):25–34.View ArticlePubMedGoogle Scholar
  11. Pot SA, Liliensiek SJ, Myrna KE, Bentley E, Jester JV, Nealey PF, Murphy CJ. Nanoscale topography-induced modulation of fundamental cell behaviors of rabbit corneal keratocytes, fibroblasts, and myofibroblasts. Invest Ophthalmol Vis Sci. 2010;51(3):1373–81.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Qazi Y, Wong G, Monson B, Stringham J, Ambati BK. Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull. 2010;81(2–3):198–210.View ArticlePubMedGoogle Scholar
  13. Jester JV, Brown D, Pappa A, Vasiliou V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering. Invest Ophthalmol Vis Sci. 2012;53(2):770–8.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Ouchemoukh S, Schweitzer P, Bey MB, Djoudad-Kadji H, Louaileche H. HPLC sugar profiles of Algerian honeys. Food Chem. 2010;121(2):561–8.View ArticleGoogle Scholar
  15. Russell L. The importance of patients’ nutritional status in wound healing. Br J Nurs. 2001;10(42 suppl):S44–9.Google Scholar
  16. Moniruzzaman M, Khalil MI, Sulaiman SA, Gan SH. Physicochemical and antioxidant properties of Malaysian honeys produced by Apis cerana, Apis dorsata and Apis mellifera. BMC Complement Altern Med. 2013;13:43. 10.1186/1472-6882-13-43.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Nisbet HO, Nisbet C, Yarim M, Guler A, Ozak A. Effects of three types of honey on cutaneous wound healing. Wounds. 2010;22:275–83.PubMedGoogle Scholar
  18. Yusof N, Ainul Hafiza AH, Zohdi RM, Bakar MZA. Development of honey hydrogel dressing for enhanced wound healing. Radiation Phys Chem. 2007;76(11–12):1767–70.View ArticleGoogle Scholar
  19. Mandal S, DebMandal M, Pal NK, Saha K. Antibacterial activity of honey against clinical isolates of escherichia coli, pseudomonas aeruginosa and salmonella enterica serovar typhi. Asian Pac J Trop Med. 2010;3(12):961–4.View ArticleGoogle Scholar
  20. Bang LM, Buntting C, Molan P. The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med. 2003;9(2):267–73.View ArticlePubMedGoogle Scholar
  21. Burdon RH. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med. 1995;18(4):775–94.View ArticlePubMedGoogle Scholar
  22. Molan PC. The role of honey in the management of wounds. J Wound Care. 1999;8(8):415–8.View ArticlePubMedGoogle Scholar
  23. Gethin GT, Cowman S, Conroy RM. The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J. 2008;5(2):85–194.View ArticleGoogle Scholar
  24. Pipelzadeh MH, Naylor IL. The in vitro enhancement of rat myofibroblast contractility by alterations to the pH of the physiological solution. Eur J Pharmacol. 1998;357(2–3):257–9.View ArticlePubMedGoogle Scholar
  25. Jester JV. Corneal crystallins and the development of cellular transparency. Semin Cell Dev Biol. 2008;19(2):82–93.View ArticlePubMedGoogle Scholar
  26. Funderburgh JL, Mann MM, Funderburgh ML. Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 2003;278(46):45629–37.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Berryhill BL, Kader R, Kane B, Birk DE, Feng J, Hassell JR. Partial restoration of the keratocyte phenotype to bovine keratocytes made fibroblastic by serum. Invest Ophthalmol Vis Sci. 2002;43(11):3416–21.PubMedGoogle Scholar
  28. Joseph R, Srivastava OP, Pfister RR. Differential epithelial and stromal protein profiles in keratoconus and normal human corneas. Exp Eye Res. 2011;92(4):282–98.View ArticlePubMedGoogle Scholar
  29. Jester JV, Ho-Chang J. Modulation of cultured corneal keratocyte phenotype by growth factors/cytokines control in vitro contractility and extracellular matrix contraction. Exp Eye Res. 2003;77(5):581–92.View ArticlePubMedGoogle Scholar
  30. Chaurasia SS, Kaur H, de Medeiros FW, Smith SD, Wilson SE. Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Exp Eye Res. 2009;89(2):590–6.View ArticlePubMedGoogle Scholar
  31. Ishizaki M, Zhu G, Haseba T, Shafer SS, Kao WW. Expression of collagen I, smooth muscle a-actin, and vimentin during the healing of alkali-burned and lacerated corneas. Invest Ophthalmol Vis Sci. 1993;34(12):3320–8.PubMedGoogle Scholar
  32. Ranzato E, Martinotti S, Burlando B. Honey exposure stimulates wound repair of human dermal fibroblasts. J Burns Trauma. 2013;1(1):32–8.View ArticleGoogle Scholar
  33. Espana EM, Kawakita T, Liu CY, Tseng SC. CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-b1. Invest Ophthalmol Vis Sci. 2004;45(9):2985–91.View ArticlePubMedGoogle Scholar
  34. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci. 1995;36(5):809–19.PubMedGoogle Scholar
  35. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res. 2010;91(3):326–35.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Han S, Lee K, Yeo J, Kim W, Park K. Biological effects of treatment of an animal skin wound with honeybee (Apis mellifera. L) venom. J Plastic Reconst Aesthet Surg. 2011;64(3):e67–72.View ArticleGoogle Scholar
  37. Iwanami H, Ishizaki M, Fukuda Y, Takahashi H. Expression of matrix metalloproteinases (MMP)-12 by myofibroblasts during alkali-burned corneal wound healing. Curr Eye Res. 2009;34(3):207–14.View ArticlePubMedGoogle Scholar
  38. Gabison EE, Huet E, Baudouin C, Menashi S. Direct epithelial-stromal interaction in corneal wound healing: Role of EMMPRIN/CD147 in MMPs induction and beyond. Prog Retin Eye Res. 2009;28(1):19–33.View ArticlePubMedGoogle Scholar
  39. Chakravarti S, Wu F, Vij N, Roberts L, Joyce S. Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea. Invest Ophthalmol Vis Sci. 2004;45(10):3475–84.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement